Theratechnologies (TSE:TH) Hits New 52-Week High – Here’s Why

Shares of Theratechnologies Inc. (TSE:TH) reached a new 52-week high on Tuesday . The stock traded as high as C$3.13 and last traded at C$3.08, with a volume of 88466 shares traded. The stock had previously closed at C$2.91.

Theratechnologies Trading Up 1.0 %

The company has a quick ratio of 0.64, a current ratio of 1.10 and a debt-to-equity ratio of 562.07. The firm has a market capitalization of C$133.80 million, a P/E ratio of -16.17, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The firm’s 50-day simple moving average is C$2.09 and its 200-day simple moving average is C$1.91.

Theratechnologies (TSE:TH) last announced its quarterly earnings data on Thursday, October 10th. The company reported C$0.09 earnings per share for the quarter. The company had revenue of C$30.96 million for the quarter. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 8.47%. Analysts anticipate that Theratechnologies Inc. will post 0.0298643 EPS for the current year.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.